22 January 2017
Paris, France – PAI Partners announces today that it has entered exclusive negotiations with Partners Group, the global private markets investment manager, and the Public Sector Pensions Investment Board, one of Canada’s largest pension investment managers, for the sale of Cerba HealthCare, a European leader in the clinical pathology business.
Paris, France – PAI Partners (“PAI”), a leading European private equity firm, announces today that it has entered exclusive negotiations with Partners Group, the global private markets investment manager, and the Public Sector Pensions Investment Board (“PSP Investments”), one of Canada’s largest pension investment managers, for the sale of Cerba HealthCare (“Cerba”), a European leader in the clinical pathology business.
Cerba HealthCare is a network of clinical pathology laboratories. It provides central, routine and specialised clinical laboratory testing services and is the only operator in Europe covering these three market segments in the clinical pathology industry.
Through its Routine Lab and Specialised Testing operations, Cerba offers a range of over 2,500 routine and specialty clinical tests used by doctors and medical institutions to diagnose, monitor and treat disease; whilst its Central Lab testing operations provide safety and efficacy testing services to pharmaceutical companies and contact research organisations worldwide.
Frédéric Stevenin, CIO of PAI Partners, said: “We are very proud to have partnered with Cerba HealthCare and helped expand the business to become a European leader in clinical pathology. We believe the company is very well positioned for the future and we wish everyone at the company success for the years ahead.”
Catherine Courboillet, CEO of Cerba HealthCare, said: “Cerba has been supported with talent and efficiency by PAI during seven years. Our managers and biologists who are shareholders of Cerba, all of our teams, our customers, our partners, can be happy about all the tremendous work performed together with PAI since 2010. This cooperation has fed Cerba’s growth and scientist, economic, social and international development. This support has also been reflected in the way PAI has managed the sale process and accomplished its favorable completion. We know that our new shareholders will pursue such a strong support for Cerba over the coming years.”
The transaction would be subject to the final and definitive agreement between the parties and customary conditions and provisions.